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Abstract
Background: Adequate intravenous ﬂuid replacement is recommended as an effective nonpharmacologic strategy for reducing
postoperative nausea and vomiting (PONV), one of the most common and stressful complications of general anesthesia. We aimed
to evaluate the effect of hydration, according to the type of ﬂuid, on PONV as previous studies have reported inconsistent results.
Methods:We performed a systemic review and meta-analysis of randomized controlled trials (RCTs) comparing infusion of colloid
with that of crystalloid in terms of PONV incidence and the need for rescue antiemetic therapies for 24hours after surgery under
general anesthesia. The effect of ﬂuid infusion according to the duration of anesthesia was also examined. A literature search was
performed, using MEDLINE, Excerpta Medica Database, Cochrane Central Register of Controlled Trials, Web of Science, and
Scopus, up to February 2018.
Results:We included 8 RCTs. Compared with the crystalloid infusion, perioperative colloid infusion did not reduce PONV
incidence, with a relative risk of 0.87 (95% conﬁdence interval [CI], 0.60–1.25). However, subgroup analysis by duration of
anesthesia showed a statistically signiﬁcant subgroup effect (P= .04, I2=77.4%), suggesting that the effect of colloid differed
from that of crystalloid depending on the duration of anesthesia. In the subgroup that underwent anesthesia for more than 3
hours, in which the patients had mostly undergone abdominal surgeries, colloid infusion signiﬁcantly reduced the incidence of
PONV compared with crystalloid infusion (RR, 0.69; 95% CI, 0.53–0.89). In the subgroup that underwent anesthesia for <3
hours, colloid infusion did not reduce the incidence of PONV compared with crystalloid infusion (RR, 1.32; 95% CI, 0.76–
2.27). The requirement for antiemetics was comparable between colloid and crystalloid infusions, with an RR of 0.93 (95% CI,
0.55–1.58).
Conclusion: Colloid administration had a more preventive effect on PONV than crystalloid administration in patients undergoing
abdominal surgery under general anesthesia for more than 3hours but did not show a preventive effect in patients undergoing
anesthesia for <3hours.
Abbreviations: CI = conﬁdence interval, PONV = postoperative nausea and vomiting, RCT = randomized controlled trial, RR =
relative risk.
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11. Introduction
Postoperative nausea and vomiting (PONV) is one of the most
common and stressful complications related to general anesthe-
sia,[1,2] and can cause patients’ dissatisfaction with their
anesthesia care.[3–5] Currently, many antiemetic medications
are used to prevent PONV. However, universal pharmacological
PONV prophylaxis is accompanied by side effects, such as
oversedation, hypotension, dry mouth, and dysphoria, and is less
cost-effective.[6,7]
A number of factors, including female sex, nonsmoking,
general anesthesia, and duration of anesthesia, have been
identiﬁed as independent risk factors for PONV.[8] Especially
most patients undergoing surgery are prone to gut ischemia
because of overnight fasting prior to general anesthesia, and this
could be associated with PONV.[6] High volume of perioperative
ﬂuid administration has been shown to reduce the incidence of
PONV in previous studies.[9–12] Adequate intravenous ﬂuid
hydration has been recommended as an effective strategy for
reducing the baseline risk for PONV in a previous consensus
[8]
Kim et al. Medicine (2019) 98:7 Medicineguideline. However, the effect of hydration, according to the
type of ﬂuid, on PONV is controversial.
Therefore, we conducted a meta-analysis with the aim of
comparing the effectiveness of colloid infusion with that of
crystalloid infusion in preventing PONV, using multiple
randomized controlled trials (RCTs).2. Materials and methods
We usedmultiple comprehensive databases to search for literature
comparing the effect of colloid infusion with that of crystalloid
infusion on the incidence of PONV. This study is based on the
Cochrane ReviewMethods, and followed the “preferred reporting
items for systematic reviews and meta-analyses” guidelines for
reporting analyses. Ethical approvalwasnot necessarybecause this
is a review of previously published articles.2.1. Data and literature source
We searched MEDLINE, Excerpta Medica Database, the
Cochrane Central Register of Controlled Trials, Web of Science,
and Scopus in February 2018. We applied no restrictions on
language or year of publication in our search.
The following keywords and Medical Subject Headings were
searched through MEDLINE: postoperative nausea and vomit-
ing, colloid, starch, and anesthesia. See Supplementary Informa-
tion 2 for the comprehensive list. Search strategies based on the
MEDLINE strategy were adapted for the other databases. After
the initial electronic search, we manually searched for further
relevant articles among the identiﬁed studies. Identiﬁed articles
were assessed for inclusion individually.2.2. Study selection
The inclusion of all studies was independently decided by 2 authors
(SHK and HJK) based on the selection criteria. Study selection was
performed through 2 levels of screening. At the ﬁrst level, we
screened titles and abstracts of the identiﬁed studies. At the second
level, we screened the full text. Studies were included in our meta-
analysis if they met the following inclusion criteria: study
population, adult patients undergoing surgery under general
anesthesia; intervention, colloid ﬂuid; control, crystalloid ﬂuid;
outcome measure, the incidence of PONV for 24hours after the
surgery, and the rescue antiemetic requirement for 24hours after the
surgery; and study design, prospective trials and RCTs. Duplicate
publications, review articles, and case reports were excluded.
2.3. Data extraction
The 2 authors (SHK andHJK) independently extracted data from
each study using a predeﬁned data extraction form. Any
disagreement unresolved by discussion was reviewed by a third
author (SHC).
The following variables were extracted from the studies: ﬁrst
author; publication year; baseline characteristics of patients; type
of surgery; intervention of ﬂuid replacement; and outcome
results, including the incidence of PONV, incidence of vomiting,
and number of patients who needed rescue antiemetics for 24
hours after the surgery.
2.4. Assessment of methodological quality
Two authors (SHK and HJK) independently assessed the
methodological qualities for each study using the Cochrane2Collaboration’s tool for assessing risk of bias. We assessed the
following domains: random sequence generation, allocation
concealment, blinding of participants and personnel, blinding of
outcome assessment, incomplete outcome data, and selective
reporting.
Publication bias was not assessable for these trials. Tests for
funnel plot asymmetry are generally only performed when at least
10 studies are included in the meta-analysis. Since our analysis
only includes 8 studies, tests for asymmetry would be ineffective
as they would be unable to differentiate chance from asymmetry.2.5. Statistical analysis
The primary outcome of our meta-analysis was the incidence of
PONV for 24hours after the surgery, and secondary outcomes
were the incidence of postoperative vomiting and antiemetic
requirements for 24hours after the surgery. For dichotomous
outcomes (incidence of PONV, postoperative vomiting, and
antiemetic requirements), the results were expressed as relative
risks (RR) with 95% conﬁdence intervals (CI). Data were pooled
using a random-effects model.
To estimate heterogeneity, we calculated the proportion of
between-study inconsistency due to true differences between
studies (rather than differences due to random error or chance)
using the I2 statistic, with values of 25%, 50%, and 75%
considered low, moderate, and high, respectively. We conducted
subgroup analyses for situations where this might affect the
results (duration of anesthesia). All analyses were performed
using RevMan version 5.2 (The Cochrane Collaboration,
London, UK).
Subgroup analyses were performed according to the duration of
anesthesia. Three and 5 studies included patients undergoing
anesthesia for more and less than 3hours, respectively. Therefore,
we divided the trials into 2 subgroupswith long and short durations
of anesthesia. Subgroup analyses were also performed according to
other well-known risk factors for PONV, including female sex,
nitrous oxide use, postoperative opioid, and type of surgery.
3. Results
3.1. Identiﬁcation of studies
Searches of all the databases resulted in 8138 articles. Of these,
579 publications were excluded as they were duplicated, 7435
publications were excluded as it was clear from the title and
abstract that they did not fulﬁll the selection criteria. For the
remaining 124 articles, we obtained full manuscripts, and
following scrutiny of these, we identiﬁed 8 potentially relevant
studies; 14 articles were excluded as they did not perform general
anesthesia. Therefore, the total number of studies included in the
review was 8 (Fig. 1).[6,13–19]
3.2. Study characteristics and patient populations
The 8 studies enrolled a total of 756 patients who underwent
surgery under general anesthesia (Table 1). Overall, 343 patients
were assigned randomly to the crystalloid group, and the
remaining 413 patients were assigned to the colloid group. Four
studies included only female patients, and another 4 studies
included both male and female patients.
All patients in both the groups were administered crystalloid as
a maintenance ﬂuid, and the interventional ﬂuids were adminis-
tered according to the study regimen. All patients in the colloid
group received hydroxyethyl starch as an interventional ﬂuid (3
[13,15–16,19]
Figure 1. Meta-analysis ﬂow-chart. RCT= randomized controlled trials.
Kim et al. Medicine (2019) 98:7 www.md-journal.comstudies used hetastarch; 4 studies used tetrastarch; and 1 study
used hetastarch, pentastarch, and tetrastarch). The interventional
ﬂuid for the crystalloid group was Ringer’s lactate in 6 studies,
normal saline in 1 study, and plasmalyte in 1 study.
In the studies by Joosten et al[17] andMoretti et al,[18] the volume
of interventional ﬂuid was determined using a goal-directed ﬂuid
therapy. In a study by Ghodraty et al,[14] intraoperative blood loss
was replaced either with colloid at 1:1 ratio or with crystalloid at
3:1 ratio.The administeredvolumeof interventionalﬂuid in these 3
studies with patients undergoing anesthesia for more than 3hours
was signiﬁcantly higher in the crystalloid group than in the colloid
group. In a study by Zia et al,[19] the volume of interventional ﬂuid
was15mL/kg for the crystalloid group, and5mL/kg for the colloid
group. In the other 4 studies, the volume of crystalloid and colloid
ﬂuids were the same.
The timing of intervention varied according to the studies. In all
3 studies with anesthesia duration longer than 3hours, interven-
tional ﬂuids were administered intraoperatively. On the other
hand, among studies with anesthesia duration<3hours, interven-
tionwas performed before induction of anesthesia in 4 studies, and
intraoperatively in only one study (by Hayes et al[16]).3Four studies only included female patients, whereas
another 4 studies[6,14,17–18] included both male and female
patients. One study by Ghodraty et al[14] was performed under
total intravenous anesthesia using propofol, whereas all other
studies used inhalation anesthetics. Nitrous oxide and air were
used in 3[13,18–19] and 4 studies,[6,14–16] respectively. Patients in 2
studies[16,19] received postoperative opioids when needed, but
patients in 4 studies[6,13–15] did not receive it. The studies by
Chaudhary et al[13] and Turkistani et al[6] only included patients
without history of smoking, motion sickness, and previous
PONV, and 4 studies[6,13,15,19] only included patients who did
not receive prophylactic antiemetics.
Two studies were performed in Belgium, and the remaining 6
studies were performed in the United States, Ireland, Saudi
Arabia, Iran, Pakistan, and India, respectively.3.3. Quality of the included studies
We have reported the risk of bias in Figure 2. One study by
Ghodraty et al[14] was at high risk with respect to the allocation
and blinding of participants. However, given the difﬁculty of
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Figure 2. Risk of bias of original studies.
Kim et al. Medicine (2019) 98:7 www.md-journal.comadditional intervention, these risks are unlikely to have affected
the further intervention during anesthesia and the outcome
assessment.
3.4. Incidence of PONV and antiemetics requirement
Six studies reported the incidence of PONV, and perioperative
colloid infusion showed a trend of reducing PONV compared
with crystalloid infusion; however, the difference was not
statistically signiﬁcant (RR, 0.87; 95% CI, 0.60–1.25) (Fig. 3).
The results of 3 studies also showed that colloid infusion did not
reduce the incidence of vomiting (RR, 0.49; 95% CI, 0.21–1.13)
(Fig. 4). Similarly, 5 studies found no difference in the antiemetics
requirement between the colloid and crystalloid groups (RR,
0.93; 95% CI, 0.55–1.58) (Fig. 5).
3.5. Subgroup analysis by duration of anesthesia
A subgroup analysis stratiﬁed by duration of anesthesia
demonstrated that perioperative colloid infusion could effectively5prevent PONV associated with anesthesia duration of more than
3hours compared with crystalloid infusion. A total of 341
patients were included in 3 studies of major surgeries, and 279
patients (81.8%) among them underwent abdominal surgeries.
The remaining 62 patients underwent gynecological, orthopedic,
or urologic surgeries. The results of this subgroup showed that
colloid infusion signiﬁcantly reduced the incidence of PONV
compared with crystalloid infusion (RR, 0.69; 95% CI, 0.53–
0.89). Only one study by Morettei et al[18] reported the
requirement for antiemetics, which was also reduced in the
colloid group compared with the crystalloid group (RR, 0.47;
95% CI, 0.29–0.78).
In contrast, perioperative colloid infusion did not improve the
incidence of PONV in studies with anesthesia duration<3hours.
A total of 415 patients were included in 5 such studies. The
patients in this subgroup underwent breast and gynecological
surgeries and cholecystectomy, which included both trans-
abdominal and laparoscopic approaches. In 3 studies, colloid
infusion did not reduce the incidence of PONV compared with
crystalloid infusion (RR, 1.32; 95% CI, 0.76–2.27). Similarly, 4
studies found no difference in the requirement for antiemetics
between the colloid and crystalloid groups (RR, 1.17; 95% CI,
0.77–1.77).3.6. Subgroup analysis of studies including only female
patients
In the subgroup of female-only studies, colloid administration did
not reduce the incidence of PONV compared with crystalloid
infusion (RR, 0.98; 95%CI, 0.55–1.76) (Fig. 6). Moreover, there
was no subgroup difference in the incidence of PONV between
the female-only and mixed (including both male and female
patients) studies (P= .74).
3.7. Subgroup analysis by nitrous oxide use
In studies with anesthesia duration <3hours, there was no
difference in the incidence of PONV between the subgroups with
nitrous oxide and air use (P= .42) (Supplementary Fig. 1, http://
links.lww.com/MD/C810). Further, in studies with anesthesia
duration more than 3hours, there was no difference in the
incidence of PONV between the 2 subgroups (P= .59) (Supple-
mentary Fig. 2, http://links.lww.com/MD/C810).3.8. Subgroup analysis by postoperative opioid use
There was no difference in the incidence of PONV between the
subgroups with and without opioid use (P= .42) (Supplementary
Fig. 3, http://links.lww.com/MD/C810).3.9. Subgroup analysis by type of surgery
In the subgroup of open abdominal surgeries, colloid infusion did
not reduce the incidence of PONV compared with crystalloid
infusion (RR, 0.80; 95% CI, 0.57–1.11) (Supplementary Fig. 4,
http://links.lww.com/MD/C810). There was no difference in the
incidence of PONV between the subgroups with open abdominal
surgeries and open hysterectomy (P= .93).4. Discussion
In this meta-analysis, we found that the effect of perioperative
colloid administration showed a clear difference according to
Figure 3. Forest plot of the effects of perioperative intravenous colloid infusion on the incidence of postoperative nausea and vomiting, according to the duration of
anesthesia. CI=conﬁdence interval.
Figure 4. Forest plot of the effects of perioperative intravenous colloid infusion on the incidence of postoperative vomiting. CI=conﬁdence interval.
Figure 5. Forest plot of the effects of perioperative intravenous colloid infusion on the requirement for antiemetic therapy, according to the duration of anesthesia.
CI=conﬁdence interval.
Kim et al. Medicine (2019) 98:7 Medicine
6
2Figure 6. Forest plot of the effects of perioperative intravenous colloid infusion on the incidence of postoperative nausea and vomiting, according to sex. CI=
conﬁdence interval.
Kim et al. Medicine (2019) 98:7 www.md-journal.comduration of anesthesia (subgroup difference, I =77.4%).
Therefore, the effect of colloid infusion on PONV should be
interpreted based on the duration of anesthesia, and it seems to
exert more preventive effect against PONV than crystalloid
infusion in patients undergoing abdominal surgery under general
anesthesia for more than 3hours.
As a routine, patients are advised to fast overnight before elective
surgery.Due to overnight fasting and intraoperative surgical losses
that often cannot be replaced adequately, hypovolemia results in
decreased blood ﬂow to the gastrointestinal tract.[13] When the
circulating volume decreases, blood is redistributed from the
splanchnic bed to more vital organs, such as the brain and
kidney.[20] Perioperative volume expansion via colloid infusion is
known to improve the perfusion of the gut mucosa,[21] and
adequate intravenous hydration is recommended as an effective
strategy for reducing the baseline risk for PONV.[8,10]According to
the previous studies, the administration of large amounts of
crystalloids reduces the incidence of PONV in patients under
general anesthesia compared with smaller amounts.[12,15,22] Based
on this meta-analysis, the effectiveness of crystalloid infusion was
comparable with that of colloid infusion in preventing PONV
following general anesthesia for<3hours, and this may be related
to the volume effect.
In 3 studies with anesthesia duration more than 3hours, 279
(81.8%) out of 341 patients underwent abdominal surgeries.
Certain types of surgeries, including abdominal surgeries, that
require long duration of general anesthesia and high opioid
consumption due to severe pain are associated with high
incidence of PONV.[8] In this review, the incidence of PONV
in patients under anesthesia for more than 3hours was
signiﬁcantly higher than that in patients under anesthesia for
<3hours (137/341 [40.2%] vs 78/264 [29.5%]; odds ratio, 1.60;
95% CI, 1.14–2.25; P= .01). In these high-risk patients under
anesthesia for more than 3hours, colloid infusion was more
effective in reducing the incidence of PONV than crystalloid
infusion.7It is difﬁcult for colloids to cross the vascular endothelium
because of their large molecular weight, and they remain in the
intravascular space longer than crystalloids. According to a
previous meta-analysis, lower ﬂuid volumes are required to
achieve similar hemodynamic end points using colloids than that
using crystalloids,[23] resulting in milder interstitial edema.[18]
Colloid administration could possibly reduce the postoperative
ileus by reducing the gut edema.[24] Particularly, most of the
patients included in the subgroup of anesthesia duration more
than 3hours underwent abdominal surgeries, and the adminis-
tered volume of interventional ﬂuid was signiﬁcantly higher in the
crystalloid group than in the colloid group. In contrast, in the
subgroup with anesthesia duration <3hours, the administered
volumes of interventional ﬂuid were comparable between the 2
groups, except for a study by Zia et al[19] These differences
between the subgroups could be the reason for the variability in
preventive effect of colloid infusion against PONV, and it is
plausible that bowel-preserving effects of colloids may have
reduced the incidence of PONV.
This review and meta-analysis has some limitations. Firstly, we
included studies that varied with respect to the type of surgery
and volume of administered interventional ﬂuid, which may
account for some of the heterogeneity observed in our analytical
results. Secondly, since the studies included in this meta-analysis
were mostly limited to cholecystectomy and gynecologic and
abdominal surgeries, the results cannot be generalized to other
surgeries. Further studies with larger numbers of patients and
greater variety of surgeries are warranted to assess the beneﬁcial
effects of perioperative intravenous colloid infusion on PONV in
patients under general anesthesia.
In conclusion, the effects of colloid infusion vary according to
the duration of surgery, being more preventive against PONV
than crystalloid infusion in patients undergoing abdominal
surgery under general anesthesia for more than 3hours. More
studies are needed to determine the beneﬁts of perioperative
colloid infusion as a preventive measure against PONV.
[7] Kranke P, Eberhart LH. Possibilities and limitations in the pharmaco-
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